Patanjali Ayurvedic Medicines has launched ‘Coronil’ anti-COVID tablets to combat and prevent the spread of the deadly coronavirus. Researched by Patanjali Research Institute with clinical trails held at NIMS University, Jaipur, the anti-corona tablet was launched by Baba Ramdev on Tuesday. Clinical control trials were carried out adhering to standardized protocols of drug discovery to evaluate its efficacy, the company said. Within the span of 3 to 15 days, all the corona positive patients transformed into negative ones without observing any mortality, the company’s release about the tablet claims.
The COVID therapy suggested by Pantanjali is applicable for adults ranging between 15-80 years of age whereas children are advised to take half the dosage prescribed for adults. Further, Patanjali urged people to practice Yoga every morning in order to stay protected from the Coronavirus infection and to boost their immune system. Apart from boosting the pulmonary system of the body, these Ayurvedic medicines strengthen the human physiology to encounter the COVID-19 infection, Patanjali claims.
READ | Rupee Rises 16 Paise To 75.87 Against US Dollar In Early Trade
READ | In Sunfeast-Maggi Dispute, Madras HC Says No One Can Claim Monopoly Over ‘Magic Masala’
This Post was originally published on republicworld.com
>> DOWNLOAD NOW <<